Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).

Fischhof PK, Saletu B, Ruther E, Litschauer G, 
Moslinger-Gehmayr R, Herrmann WM.

Psychiatric Hospital Baumgartner Hohe, 
Vienna, Austria.
Neuropsychobiology 1992;26(1-2):65-70

ABSTRACT

This trial was performed to investigate the efficacy of pyritinol in the treatment of senile dementia. Initially, a total of 183 inpatients were screened for eligibility. Of 164 patients who met the inclusion criteria, 156 completed the trial.  Allocation of the patients to the Senile Dementia of the Alzheimer Type group or the Multi-Infarct Dementia group was based on the Hachinski Ischemic Score, computed tomography scans and electroencephalographic (EEG) findings. In a 12-week double-blind treatment phase either 200 mg pyritinol dihydrochloride-monohydrate or placebo was given 3 times daily. Confirmatory statistics included item 2 of the Clinical Global Impression, the total score of the Short Cognitive Performance Test (Syndrom Kurz Test) and the factor 'cognitive disturbances' of the Sandoz Clinical Assessment Geriatric scale. In addition, data on tolerance, of EEG brain mapping and of a responder analysis were evaluated based on descriptive statistics. The therapeutic efficacy of pyritinol was clearly demonstrated by confirmatory analysis as the drug was statistically significantly superior to placebo in all 3 target variables.  The clinical relevance of the outcome was underlined by the analysis of the descriptive variables and by the convergence found at the different observation levels.  The EEG mapping demonstrated significant differences between placebo and pyritinol, with the latter decreasing slow and increasing fast alpha and beta activity, which reflects improvement of vigilance.  Based on the results of this trial, it can be accepted that the therapeutic effect of pyritinol is superior to placebo in patients with mild to moderate dementia of both degenerative and vascular etiology

Deprenyl Alzheimer's research                                                   www.deprenyl.info
       deprenyl   improves the performance of patients with Alzheimer's disease
       deprenyl   in the treatment of Alzheimer's disease
CDP Choline Alzheimer's research        !                                 www.cdpcholine.info
       CDP choline  may be useful in the treatment of Alzheimer's
       CDP choline  significant improvement after 1 month in early-onset Alzheimer's
       CDP choline  effects on cognition in patients with Alzheimer's
       CDP choline  significant improvement in Alzheimer's after 1 month  
       CDP choline  improved mental performance in Alzheimer's
Vinpocetine Alzheimer's research                  !                         www.vinpocetine.info
       vinpocetine  enhances oxygen release in vascular dementia  . 
       vinpocetine  article 
Piracetam Alzheimer's research                   !                            www.piracetam.info
       piracetam  improved alertness in Alzheimer's patients
       piracetam  improved cerebral glucose metabolism in Alzheimer's patients
       piracetam  use in Alzheimer's
       piracetam  therapy in Alzheimer's
       piracetam  a one year study of Alzheimer's patients 
       piracetam  article
Idebenone Alzheimer's research                      !                       www.idebenone.info
       Idebenone  versus Tacrine in Patients with Alzheimer's disease
       Idebenone  efficacy of idebenone in the treatment of Alzheimer's disease
       Idebenone  Nerve Growth Factor synthesis stimulators in Alzheimer's disease
       Idebenone  in the treatment of dementia of the Alzheimer type
       Idebenone  cognitive enhancement therapy for Alzheimer's disease
       Idebenone  study in the treatment of Alzheimer's disease
       Idebenone  two year study indicates idebenone slows Alzheimer's progression
       Idebenone  stimulates NGF synthesis in the treatment of Alzheimer's disease
       Idebenone  article
Pyritinol Alzheimer's research                          !                        www.pyritinol.info
       pyritinol  improved cognition in 100 dementia patients
       pyritinol  produced significant improvement in 40 dementia patients
       pyritinol  had therapeutic effect on 156 senile dementia patients
       pyritinol  improved cognitive performance in 26 dementia patients
       pyritinol  improved cerebral glucose metabolism in dementia
       pyritinol  article
 
.

Memantine Alzheimer's research                                              www.memantine.info

       Memantine  efficacy in patients with dementia
       Memantine  in senile dementia, Alzheimer type
       Memantine  and advanced dementia
       Memantine  for neuroprotection in dementia
       Memantine  in vascular dementia
       Memantine  in mild to moderate dementia
Galantamine Alzheimer's research                                            www.galantamine.cc
       galantamine  efficacy of galantamine in dementia and Alzheimer's disease
       galantamine  for Alzheimer's disease
       galantamine  novel approach to the treatment of Alzheimer disease
       galantamine  maintaining cognitive function in Alzheimer disease
       galantamine  maintaining functional abilities in Alzheimer disease
       galantamine  a new Alzheimer disease drug with a past life
       galantamine  treating vascular dementia with galantamine
       galantamine  rationale for switching from donepezil to galantamine
       galantamine  switching previous therapies for Alzheimer's disease to galantamine
       galantamine  its use in Alzheimer's
       galantamine  a new treatment for Alzheimer's
       galantamine  benefits to Alzheimer's patients
       galantamine  efficacy in mild to moderate Alzheimer's disease
       galantamine  effects on the course of Alzheimer's disease
       galantamine  a 5 month Alzheimer's study
       galantamine  effects in patients previously treated with donepezil
       galantamine  a six month Alzheimer's study
       galantamine  therapeutic effects beyond cognition in Alzheimer's disease
       galantamine  cognitive function in Alzheimer's disease
       galantamine  maintains cognitive function for at least 1 year
       galantamine  increase the density of brain nicotinic receptors
       galantamine  treatment for mild to moderate Alzheimer's disease.
       galantamine  may be effective as a cognition-enhancer in Alzheimer's disease
       galantamine  differs from other acetylcholine esterase inhibitors
       galantamine  safety and tolerability
       galantamine  dual mode of action for Alzheimer's disease
       galantamine  provides benefits for Alzheimer's for up to six months  .  
            article    Galantamine fights Alzheimer's
            article    Why galantamine is better than Aricept® and Exelon ®
            article    Galantamine can sharpen your mental edge
            article    Galantamine helps save memory
            article    Galantamine for combating mental decline
            article    Galantamine opens the channels of your memory
            article    Galantamine boosts memory
            article    Galantamine rescues brain cells
            article    Galantamine helps your memory
            article    Galantamine memory enhancement therapy
            article    Galantamine may help stave off dementia
            article    Galantamine enhances neurotransmission
            article    Galantamine increases acetylcholline
            article    Galantamine has benefits over Aricept®

 

 

 
 
 
 

 

 

Hit Counter